THE AUCTION GALLERY
is proud to feature the works of 22 artists and photographers who
have donated their work toward raising money for the ALS
Therapy Development Foundation. All
auction proceeds will go directly to the Foundation.
on "Auction Gallery" to view the art. Each piece is linked
to ebay for bidding. The auction starts on October
8 and last for 10 days.
lateral sclerosis (ALS), also known as Lou Gehrigs disease,
is a fatal neurological disorder that causes muscle
atrophy, paralysis, and respiratory failure. ALS has no prejudice
— it occurs worldwide, with no age, ethnic, or economic boundaries.
30,000 Americans have ALS today.
• Up to 8,000 new cases are diagnosed in the U.S. each
• 90% of patients die within 5 years of diagnosis.
• There is no known treatment or cure.
has stricken two people connected to TheScreamOnline.
One is the brother of a dear photographer friend, who recently
succumbed to the disease after a long struggle. The other is L.A.
studio musician, composer, and writer Steve Fowler, whose poetry
can be seen in the April
2002 issue of the magazine.
few of the more recognizable names of people that suffered with
ALS include Jim Catfish Hunter, Stephen Hawking, and,
of course, Lou Gehrig. More recently Bruce Edwards, caddy for
golf pro Tom Watson, also was diagnosed with ALS, along with former
pro golfer Jeff Julian. Find out more about their efforts to slow,
arrest, and cure ALS at www.driving4life.org.
— The ALS Therapy Development Foundation
is a nonprofit biotechnology company in Cambridge, Massachusetts,
dedicated to developing effective treatments for todays
ALS patients. It combines the passion and dedication
of a nonprofit organization with the entrepreneurial
and scientific spirit of a biotechnology company.
Our laboratory, the leading drug discovery program
for ALS, bridges a critical research gap.
Our in-house expertise translates research into potential
drug candidates by screening drugs in the SOD1 mouse
model of ALS.
Our scientific collaborations bring the most promising
leads closer to FDA approval.
We share emerging knowledge on the disease with patients,
physicians, and researchers as quickly and comprehensively
Every decision is made in the interest of finding
effective treatments for people living with ALS.
Our unique approach accelerates drug development for
Heywood founded ALSTDF in 1999, four months after his
brother Stephen was diagnosed with ALS at age 29. Frustrated
by the lack of treatment options and determined to save
his brother and all others living with ALS, he left his
job at the Neurosciences Institute in California and,
together with his family and friends, he founded the worlds
first ALS-focused nonprofit biotechnology company from
his parents basement in a Boston suburb.
Today, one mans personal tragedy now provides hope
for thousands of people suffering from ALS and points
to new possibilities for fighting other neurological disorders.
ALSTDF now operates out of a high-tech research facility
in Boston where a dedicated team of researchers and staff
search each day for a treatment and cure on behalf of
todays ALS patients.
the last four years, ALSTDF has:
Raised more than $11 million to support work to slow,
arrest, and cure ALS.
Established the leading drug discovery program for ALS.
Collected and evaluated a list of nearly 400 proposed
treatments for ALS.
Partnered with 28 pharmaceutical and biotechnology companies
to obtain and test potential treatments for ALS.
Launched 9 collaborative research projects, working with
leading academic researchers in other fields to focus
efforts on ALS.
Discovered two new drug targets in ALS that may open up
new areas of drug research in ALS.
Advanced two potentially promising treatments for ALS
into the clinical investigation stage.
Therapy Development Foundation
215 First Street, Cambridge, MA 02142 U.S.A.
more information on ALSTDF and how you can help,
please visit www.als.net.
is extremely proud of each of the 22 artists and photographers
for their generous donation toward raising money for
ALS therapy development. At the same time, each high
bidder in the auction will also be participating in
this most worthy cause, and we thank you all.
THE AUCTION GALLERY